Association of Angiogenic and Inflammatory Markers with Power Doppler Ultrasound Vascularity Grade and DAS28-CRP in Early Rheumatoid Arthritis: A Comparative Analysis

Biomed Res Int. 2018 Nov 25:2018:6906374. doi: 10.1155/2018/6906374. eCollection 2018.

Abstract

Objective: Upregulation of various proinflammatory and angiogenic mediators orchestrates the typical pathological synovial alterations in rheumatoid arthritis (RA). DAS28-CRP is commonly used for assessment of RA disease activity and power Doppler ultrasonography (PDUS) is an important modality for assessing synovial vascularity. This study was intended to look for the association of various inflammatory and angiogenic mediators, with respect to different PDUS vascularity grades and disease activity status, in early RA patients.

Methods: 50 early RA patients (<6 months disease duration) with either moderate or high disease activity and 30 healthy controls were included in this study. RA patients were subcategorized based on PDUS vascularity grading of wrist joints. Serum levels of proinflammatory cytokines [tumor necrosis factor-α (TNF- α); interleukin-6(IL-6)] and angiogenic markers [angiopoietin-1 and 2 (Ang-1 and Ang-2); vascular endothelial growth factor (VEGF) ] were measured and compared among different patient subgroups.

Results: Among 50 patients, 22 and 28 patients had moderate and high DAS28-CRP score, respectively. Patients with grade 3 PDUS score, even with moderate DAS value, showed a significant rise in Ang-1 (p<0.02), VEGF (p<0.008), Ang-2 (p <0.001), and TNF-α (p<0.005) level compared to grade 2 PDUS patients with high DAS values.

Conclusion: Higher serum level of angiogenic and inflammatory markers was noted among patients with moderate disease activity but with advanced PDUS vascularity (grade 3) in comparison to high disease activity group with less severe PDUS vascularity (grade 2). PDUS vascularity grading better reflects some markers of angiogenesis and inflammation, than composite disease activity index.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Adult
  • Antirheumatic Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / metabolism*
  • Biomarkers / metabolism*
  • Cross-Sectional Studies
  • Cytokines / metabolism
  • Female
  • Humans
  • Inflammation / drug therapy
  • Inflammation / metabolism*
  • Male
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / metabolism*
  • Synovial Membrane / drug effects
  • Synovial Membrane / metabolism
  • Synovitis / drug therapy
  • Synovitis / metabolism
  • Tumor Necrosis Factor-alpha / metabolism
  • Ultrasonography, Doppler / methods
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Antirheumatic Agents
  • Biomarkers
  • Cytokines
  • Tumor Necrosis Factor-alpha
  • Vascular Endothelial Growth Factor A